Literature DB >> 35306568

Titanium(IV) immobilized affinity chromatography facilitated phosphoproteomics analysis of salivary extracellular vesicles for lung cancer.

Amir Wahid1, Amir Sohail1, Huiyu Wang1, Miao Guo1, Lu Zhang1, Yin Ji2, Peng Wang3, Hua Xiao4.   

Abstract

Extracellular vesicles (EVs) play critical roles in intercellular communications, which contain valuable biomarkers for the detection of cancers. Phosphoproteomics analysis of human saliva EVs (sEVs) can help to discover lung cancer-related candidates. Due to the low abundance of phosphoproteins in sEVs, an efficient, reproducible, and cost-effective strategy is required for their enrichment. Here, we compared the latest phosphopeptide techniques, including TiO2, ZrO2, CaTiO3, and Ti4+-IMAC (immobilized metal affinity chromatography) methods, for phosphopeptide isolation. Our data demonstrated that Ti4+-IMAC was the superior one. By using the optimized Ti4+-IMAC approach, we identified more than 500 sEV phosphopeptides. Quantitative proteomics was employed to comprehensively decipher the sEV phosphoproteome of the normal group (n = 6) and lung cancer group (n = 6). Accordingly, 524 and 333 phosphopeptides were enriched, respectively, which corresponded to 439 and 282 phosphoproteins. In total, 857 unique sEV phosphopeptides corresponding to 721 phosphoproteins were revealed. Among 493 identified phosphosites, 37 were upregulated (> 1.5) and 217 were downregulated (< 0.66) in the cancer group. Our data collectively demonstrated that Ti4+-IMAC is an efficient and reproducible technology for comprehensive analysis of sEV phosphoproteome. Differentially expressed sEV phosphoproteins and phosphosites might be used for the detection of lung cancer non-invasively.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Extracellular vesicles; Lung cancer; Phosphoprotein; Saliva; Ti4+-IMAC

Mesh:

Substances:

Year:  2022        PMID: 35306568     DOI: 10.1007/s00216-022-04013-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  3 in total

1.  TMEM16A as a Potential Biomarker in the Diagnosis and Prognosis of Lung Cancer.

Authors:  Cong Hu; Ronggui Zhang; Depeng Jiang
Journal:  Arch Iran Med       Date:  2019-01-01       Impact factor: 1.354

2.  Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.

Authors:  Tomoki Nakagawa; Yoshimasa Inoue; Hiroko Kodama; Hitoshi Yamazaki; Kenji Kawai; Hiroshi Suemizu; Ryota Masuda; Masayuki Iwazaki; Shunsuke Yamada; Yoshito Ueyama; Hiroshi Inoue; Masato Nakamura
Journal:  Oncol Rep       Date:  2008-08       Impact factor: 3.906

3.  Fibrinogen Alpha Chain Knockout Promotes Tumor Growth and Metastasis through Integrin-AKT Signaling Pathway in Lung Cancer.

Authors:  Meng Wang; Guangxin Zhang; Yue Zhang; Xuelian Cui; Shuaibin Wang; Song Gao; Yicun Wang; Ying Liu; Jeeyoo H Bae; Wei-Hsiung Yang; Lei S Qi; Lizhong Wang; Runhua Liu
Journal:  Mol Cancer Res       Date:  2020-03-23       Impact factor: 5.852

  3 in total
  1 in total

1.  A Ti/Nb-functionalized COF material based on IMAC strategy for efficient separation of phosphopeptides and phosphorylated exosomes.

Authors:  Xiaoya Zhang; Quanshou Feng; Zehu Xie; Fuxing Xu; Yinghua Yan; Chuanfan Ding
Journal:  Anal Bioanal Chem       Date:  2022-09-22       Impact factor: 4.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.